Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Verisk (VRSK) slides 5% as investors digest recent guidance, leverage-funded buyback, and mixed analyst price-target resets

None

Verisk Analytics (VRSK) is down 5.0% today. Here is some analysis on what might have caused this price movement.

Analysis: A single, definitive catalyst for today’s drop is not clearly identifiable from public disclosures, but the move appears tied to continued post-earnings repositioning after the company’s 2026 outlook and capital-return actions. Investors may also be weighing incremental balance-sheet leverage used to support an accelerated share repurchase, alongside recent price-target reductions from multiple covering firms.

Details:

  • In its latest quarterly results, the company discussed temporary demand headwinds tied to unusually low weather activity, even as it reiterated confidence in longer-term targets.
  • The company increased its total share repurchase authorization to $2.5 billion and also declared a $0.50 per share dividend payable March 31, 2026 (record date March 13, 2026), which can shift near-term trading dynamics around capital return and valuation.
  • A subsequent filing outlined financing and accelerated share repurchase arrangements, a structure that can increase leverage and sometimes sparks concerns about financial flexibility and interest expense sensitivity.
  • Separately, a cluster of analyst updates in late February and early March showed mixed actions, including multiple price-target cuts alongside at least one upgrade—an overall setup that can amplify volatility when sentiment is fragile.
  • Sources:

    Verisk investor release, U.S. securities filing, Benzinga

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $VRSK Insider Trading Activity

    VRSK Insider Trades

    $VRSK insiders have traded $VRSK stock on the open market 11 times in the past 6 months. Of those trades, 5 have been purchases and 6 have been sales.

    Here’s a breakdown of recent trading of $VRSK stock by insiders over the last 6 months:

    • LEE SHAVEL (Chief Executive Officer) has made 0 purchases and 2 sales selling 2,200 shares for an estimated $480,766.
    • ELIZABETH MANN (Chief Financial Officer) has made 0 purchases and 4 sales selling 1,300 shares for an estimated $285,512.
    • GREGORY HENDRICK has made 2 purchases buying 1,000 shares for an estimated $198,150 and 0 sales.
    • KIMBERLY S STEVENSON purchased 1,000 shares for an estimated $179,200
    • JEFFREY J DAILEY purchased 500 shares for an estimated $108,515
    • SABRA R. PURTILL purchased 450 shares for an estimated $98,077

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $VRSK Hedge Fund Activity

    We have seen 487 institutional investors add shares of $VRSK stock to their portfolio, and 579 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $VRSK Government Contracts

    We have seen $6,557,380 of award payments to $VRSK over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

    $VRSK Congressional Stock Trading

    Members of Congress have traded $VRSK stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.

    Here’s a breakdown of recent trading of $VRSK stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    $VRSK Analyst Ratings

    Wall Street analysts have issued reports on $VRSK in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Barclays issued a "Overweight" rating on 10/30/2025
    • RBC Capital issued a "Outperform" rating on 10/30/2025
    • JP Morgan issued a "Overweight" rating on 10/30/2025
    • Wells Fargo issued a "Overweight" rating on 10/30/2025
    • Rothschild & Co issued a "Sell" rating on 10/16/2025
    • Seaport Global issued a "Buy" rating on 10/01/2025

    To track analyst ratings and price targets for $VRSK, check out Quiver Quantitative's $VRSK forecast page.

    $VRSK Price Targets

    Multiple analysts have issued price targets for $VRSK recently. We have seen 10 analysts offer price targets for $VRSK in the last 6 months, with a median target of $235.0.

    Here are some recent targets:

    • C. Gregory Peters from Raymond James set a target price of $260.0 on 03/02/2026
    • Jason Haas from Wells Fargo set a target price of $240.0 on 03/02/2026
    • Andre Benjamin from Goldman Sachs set a target price of $206.0 on 02/19/2026
    • David Motemaden from Evercore ISI Group set a target price of $216.0 on 02/19/2026
    • Ashish Sabadra from RBC Capital set a target price of $230.0 on 02/19/2026
    • Andrew Steinerman from JP Morgan set a target price of $220.0 on 02/19/2026
    • Toni Kaplan from Morgan Stanley set a target price of $270.0 on 12/17/2025

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles